Recent experience confirms that stand-alone memory care communities are ‘insufficient,’ Thrive executives...
By
Lois A. Bowers
Jun 12, 2019
As the Thrive Senior Living name disappears from real estate investment trust LTC Properties’ portfolio, the Atlanta-based operator said Tuesday that it is a good time to step away from stand-alone memory...
Is Alzheimer’s research about to go down a new path?
By
John O'Connor
May 07, 2019
By finding ways to prevent connection losses, the disease progression potentially could be delayed or even reversed, experts said.
‘Whole concept of senior living will change’ if Alzheimer’s drug is approved
By
Lois A. Bowers
Oct 24, 2019
“The whole concept of senior living will change,” CNBC’s Jim Cramer said Tuesday, discussing the news that Biogen and Eisai plan to seek regulatory approval of their investigational treatment for...
Exercise may delay brain deterioration in those at risk of Alzheimer’s, study finds
By
Lois A. Bowers
Sep 18, 2019
Exercising several times a week may delay brain deterioration in those who are at high risk of Alzheimer’s disease, according to a study published in the Journal of Alzheimer’s Disease.
More news for Thursday, Feb. 16
Feb 15, 2017
Crash test dummies are being altered to match aging, heavier population … Alzheimer’s outlook far from bleak … Seven couples renew vows at assisted living community for Valentine’s...
CDC: Those who reach 65 can expect to live almost 20 more years
By
Lois A. Bowers
Jan 29, 2017
Older adults who reach the age of 65 in the United States will live an average of 19.4 years longer, according to a data brief recently released by the Centers for Disease Control and Prevention’s...
Statins may help reduce risk for Alzheimer’s disease
By
John O'Connor
Dec 14, 2016
Drugs frequently prescribed to treat high cholesterol might also help reduce the odds a person will suffer from Alzheimer’s disease, a new examination of Medicare data has found.
FDA fast-tracks Alzheimer’s drug
By
Lois A. Bowers
Aug 22, 2016
The FDA has granted fast-track status to a drug that is in clinical trials for Alzheimer’s disease, according to the developers of the medication.
Experimental drug may improve memory
By
Lois A. Bowers
Dec 30, 2015
An experimental drug that may improve memory is being tested in a phase 1 safety trial.
Firearm-owning veterans receptive to safety discussions in routine care
Jul 03, 2023
The findings are based on a survey encompassing six clinical contexts involving heightened risk for firearm injury.